H.U. Group Holdings, Inc. (TYO:4544)
3,879.00
-49.00 (-1.25%)
Nov 4, 2026, 3:30 PM JST
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 62.59B JPY in the quarter ending June 30, 2026, with 1.95% growth. This brings the company's total for the last twelve months to 248.56B, up 1.47% year-over-year. In the fiscal year ending March 31, 2026, H.U. Group Holdings had annual revenue of 247.36B with 1.78% growth. That makes H.U. Group Holdings the 5,831st largest company in the world by revenue and 598th in Japan.
Revenue (ttm)
248.56B
Revenue Growth
+1.47%
P/S Ratio
0.84
Revenue / Employee
48.20M
Employees
5,157
Market Cap
209.80B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full H.U. Group Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 247.36B | 4.34B | 1.78% |
| Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
| Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
| Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
| Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.69T |
| Otsuka Holdings | 2.69T |
| Chugai Pharmaceutical | 1.41T |
| HOYA Corporation | 1.01T |
| Ship Healthcare Holdings | 731.21B |
| Ain Holdings | 691.99B |
| Nipro | 668.86B |
| Create SD Holdings | 505.08B |